Ovid seeks metamorphosis into public company with $86M IPO

This follows on from a fairly quiet start to the year in terms of public offerings from biotech, although just this week Biohaven Pharmaceutical filed to raise up to $100 million in its IPO attempt to … Ovid help out on the Osaka-based company’s …
( read original story …)


Related Post

CORRECTED-Nikkei extends 2-year highs on upbeat gl...
views 186
TOKYO, Oct 4 (Reuters) - Japan’s Nikkei share aver...
Light earthquake, 4.7 mag strikes near Nemuro in J...
views 25
A light earthquake with magnitude 4.7 (ml/mb) was ...
Personal finance show: student property opportunit...
views 31
In this week's show, Nick Barker, co-manager of GC...
Tennis: Osaka lost in her virtual world
views 55
PARIS (Reuters) - The life of a professional athle...
With two Japanese cryptocurrencies coming, ATMs ma...
views 170
Hirano was speaking at Fin/Sum Week 2017, organize...
Spending Rises in Japan But Inflation Remains Weak
views 231
Japanese household spending hit its highest for tw...
Fed Cup: Johanna Konta wins after Heather Watson l...
views 80
Osaka broke again to take a 3-1 lead and, after fe...
Kenyans Kabuu, Jemeli and Cheyech Lead Nagoya Wome...
views 106
The Nagoya Women's Marathon is the largest women-o...
Tokyo cops: Man licked face of girl, 11, after get...
views 221
Tokyo Metropolitan Police have arrested a 41-year-...
JAPAN: Nikkei corrects another -0.6%, almost signa...
views 199
06:57a Asian stocks mixed, still Trump worrying as...